Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals
CHIMIA · 2025
DOI: 10.2533/chimia.2025.606 ↗Kurz gefasst
Fachartikel in der Zeitschrift CHIMIA, 2025. Verfasst von Michael U Luescher und 3 weiteren Autor:innen. Beteiligte Einrichtung: Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. michael-1.luescher@novartis.com. Hauptthemen laut MEDLINE: Drug Industry, Solvents. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pharmaceutical industries play a crucial role in enhancing global health outcomes; however, like many other sectors, they also encounter significant environmental challenges. The extraction of raw materials and the manufacture of active pharmaceutical ingredients (APIs) result in considerable waste production, substantial resource consumption, and environmental pollution. Transitioning from traditional linear economic models to circular processes presents an opportunity for more sustainable pharmaceutical operations that benefit both communities and the environment. The circular economy framework – grounded in resource efficiency, waste minimization, and material regeneration – offers a path towards comprehensive sustainability in pharmaceutical practices. This is particularly relevant in the area of solvent usage, which accounts for over half the input mass and associated waste in most processes. This article examines the application of circular economy principles to solvent selection within process design, highlighting its significance as a central component of sustainable pharmaceutical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. michael-1.luescher@novartis.com.
- Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. alessia.valotta@novartis.com.
- Chemical & Analytical Development, Novartis Pharma AG, CH-4056 Basel, Switzerland.. fabrice.gallou@novartis.com.
Zitieren
APA
Luescher, M. U., Valotta, A., Haber, J., & Gallou, F. (2025). Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals. CHIMIA. https://doi.org/10.2533/chimia.2025.606
Vancouver
Luescher MU, Valotta A, Haber J, Gallou F. Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals. CHIMIA. 2025. doi:10.2533/chimia.2025.606
BibTeX
@article{Luescher2025,
author = {Luescher, Michael U and Valotta, Alessia and Haber, Julien and Gallou, Fabrice},
title = {Solvent Selection for Circular Designs – Bridging Process Needs and Sustainability Goals},
journal = {CHIMIA},
year = {2025},
doi = {10.2533/chimia.2025.606}
}
EUVIMED